RETATRUTIDE 5MG
$20.00
Retatrutide is an experimental PEPTIDE for the treatment of obesity and type 2 diabetes mellitus (T2DM) currently BEING RESEARCHED. It is a single peptide that acts as a triple agonist, meaning it activates three key receptors involved in regulating metabolism and appetite: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.